SODIUM VALPROATE for Maternal exposure timing unspecified: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 14 adverse event reports in the FDA FAERS database where SODIUM VALPROATE was used for Maternal exposure timing unspecified.
Most Reported Side Effects for SODIUM VALPROATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Foetal exposure during pregnancy | 12 | 12.0% | 2 | 1 |
| Overdose | 10 | 10.0% | 2 | 3 |
| Angioedema | 9 | 9.0% | 0 | 0 |
| Toxicity to various agents | 9 | 9.0% | 0 | 6 |
| Syncope | 7 | 7.0% | 0 | 0 |
| Anxiety | 5 | 5.0% | 0 | 0 |
| Foetal anticonvulsant syndrome | 5 | 5.0% | 0 | 1 |
| Hypotension | 5 | 5.0% | 0 | 2 |
| Malaise | 5 | 5.0% | 0 | 0 |
| Metabolic acidosis | 5 | 5.0% | 0 | 3 |
| Non-alcoholic steatohepatitis | 5 | 5.0% | 0 | 0 |
| Weight increased | 5 | 5.0% | 0 | 0 |
Other Indications for SODIUM VALPROATE
Other Drugs Used for Maternal exposure timing unspecified
VALPROATE (1,477)
ADALIMUMAB (1,280)
NATALIZUMAB (492)
RITONAVIR (486)
EMTRICITABINE\TENOFOVIR DISOPROXIL (333)
LOPINAVIR\RITONAVIR (278)
DIVALPROEX (254)
INTERFERON BETA-1A (245)
DIMETHYL (212)
ATAZANAVIR (169)